Investigation of Cortical Thickness Abnormalities in Lithium-Free Adults With Bipolar I Disorder Using Cortical Pattern Matching

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.

From the Laboratory of NeuroImaging, Department of Neurology, and the Ahmanson-Lovelace Brain Mapping Center, UCLA School of Medicine, Los Angeles; the Departments of Biostatistics and of Psychiatry and Biobehavioral Sciences, UCLA; the Schizophrenia Research Institute, Darlinghurst, New South Wales, Australia; the Priority Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, New South Wales; the Department of Psychiatry, VA Greater Los Angeles Healthcare System; and West Los Angeles Healthcare Center.